by Eric Christianson | Mar 4, 2026 | Neurology, Pain, and Musculoskeletal Case Studies
Medication reviews in patients with rheumatoid arthritis often uncover clinically significant drug therapy problems. Methotrexate toxicity, drug interactions, and therapeutic duplication are common issues that pharmacists must proactively identify. In this case-based...
by Eric Christianson | Jun 18, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Rheumatoid arthritis (RA) often requires complex, long-term medication regimens. This polypharmacy increases the risk of clinically significant drug interactions that can impact efficacy and safety. Below are five of the most important drug interactions encountered in...
by Eric Christianson | Apr 26, 2023 | Hematology and Immunology Case Studies
I want to address an email from a recent podcast listener regarding the appropriate way to take folic acid with methotrexate. Specifically, what is my take on methotrexate and folic acid same-day dosing? First, let’s start with some basics. Folic Acid (vitamin...
by Eric Christianson | Jul 31, 2022 | Hematology and Immunology Medication and Disease State Clinical Pearls
Sulfasalazine is classified as a DMARD (Disease-modifying antirheumatic drug) as well as a 5-aminosalicylic acid derivative. The most common use in clinical practice that I’ve seen sulfasalazine used for is rheumatoid arthritis, but it can also play a role in...
by Eric Christianson | Mar 22, 2020 | Clinical Pharmacy News and New Drug Updates
The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is...
